Skip to main content

Table 1 Individual patient anthracycline dosage, time to first diagnosis and fractional shortening percentage

From: Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy

Individual

Druga

Cumulative Dose

(mg/m2)

FS %b

Time (days) to initial abnormal echo.c

1

Daun

435

14

276

2

Daun, Mitox

410

23.3

145

3

Dox

356

22.9

267

4

Daun, Dox

325

6

1343

5

Dox

260

23.9

81

6

Dox

255

23.1

64

7

Daun

204

19.7

71

8

Daun

200

21.5

26

9

Daun, Dox

178

23

1805

10

Daun, Dox

175

23.5

253

11

Daun, Ida

161

23.9

17

12

Daun, Dox

147

20.5

1151

13

Daun, Dox

136

19.9

88

14

Dox

72

23.3

214

15

Dox

51

23.9

106

  1. aDaun daunorubicin; Dox doxorubin; Mitox mitroxantrone; Ida Idarubicin. b most abnormal record of fractional shortening. cecho echocardiography